SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/17/14 Biolase, Inc 10-K 12/31/13 76:14M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.28M 2: EX-4 Ex-4.4 HTML 29K 3: EX-10 Ex-10.42 HTML 61K 4: EX-21 Ex-21.1 HTML 21K 5: EX-23 Ex-23.1 HTML 23K 6: EX-31 Ex-31.1 HTML 29K 7: EX-31 Ex-31.2 HTML 29K 8: EX-32 Ex-32.1 HTML 25K 9: EX-32 Ex-32.2 HTML 25K 53: R1 Document and Entity Information HTML 53K 43: R2 Consolidated Balance Sheets HTML 144K 51: R3 Consolidated Balance Sheets (Parenthetical) HTML 51K 55: R4 Consolidated Statements Of Operations And HTML 107K Comprehensive Loss 71: R5 Consolidated Statements Of Shareholders' Equity HTML 101K (Deficit) 45: R6 Consolidated Statements Of Cash Flows HTML 176K 50: R7 Basis of Presentation HTML 55K 39: R8 Summary of Significant Accounting Policies HTML 152K 30: R9 Supplementary Balance Sheet Information HTML 122K 72: R10 Intangible Assets and Goodwill HTML 92K 57: R11 Lines of Credit and Other Borrowings HTML 44K 56: R12 Income Taxes HTML 190K 62: R13 Commitments and Contingencies HTML 56K 63: R14 Stockholders' Equity HTML 274K 61: R15 Segment Information HTML 49K 64: R16 Concentrations HTML 26K 52: R17 Subsequent Events HTML 38K 54: R18 Schedule II-Consolidated Valuation and Qualifying HTML 88K Accounts and Reserves 60: R19 Accounting Policies (Policies) HTML 306K 76: R20 Summary of Significant Accounting Policies HTML 109K (Tables) 67: R21 Supplementary Balance Sheet Information (Tables) HTML 129K 47: R22 Intangible Assets and Goodwill (Tables) HTML 83K 58: R23 Income Taxes (Tables) HTML 183K 49: R24 Commitments and Contingencies (Tables) HTML 31K 24: R25 Stockholders' Equity (Tables) HTML 229K 68: R26 Segment Information (Tables) HTML 41K 73: R27 Basis of Presentation - Additional Information HTML 52K (Detail) 34: R28 Estimated Useful Lives of Property, Plant and HTML 28K Equipment (Detail) 33: R29 Changes in Initial Product Warranty Accrual and HTML 41K Expenses Under Initial and Extended Warranties (Detail) 37: R30 Classification of Compensation Expense Associated HTML 32K with Share-Based Payments (Detail) 38: R31 Assumptions Used in Estimating Fair Value of Stock HTML 35K Options Granted (Detail) 40: R32 Summary of Significant Accounting Policies - HTML 57K Additional Information (Detail) 22: R33 Components of Accounts Receivable, Net of HTML 31K Allowance (Detail) 65: R34 Components of Inventory (Detail) HTML 34K 46: R35 Summary of Property, Plant, and Equipment (Detail) HTML 45K 48: R36 Components of Accrued Liabilities (Detail) HTML 51K 27: R37 Summary of Deferred Revenue (Detail) HTML 40K 75: R38 Supplementary Balance Sheet Information - HTML 48K Additional Information (Detail) 16: R39 Intangible Assets and Related Accumulated HTML 56K Amortization (Detail) 41: R40 Intangible Assets and Goodwill - Additional HTML 44K Information (Detail) 70: R41 Lines of Credit and Other Borrowings - Additional HTML 137K Information (Detail) 26: R42 Summary of Income Tax Current and Deferred HTML 69K Provision (Benefit) (Detail) 32: R43 Federal Income Tax Provision Compared With HTML 63K Statutory Rates (Detail) 36: R44 Summary of Net Deferred Tax Assets and Net HTML 87K Deferred Tax Liabilities (Detail) 44: R45 Summary of Unrecognized Tax Benefits (Detail) HTML 31K 21: R46 Income Taxes - Additional Information (Detail) HTML 58K 29: R47 Commitments and Contingencies - Additional HTML 41K Information (Detail) 18: R48 Future Minimum Rental Commitments Under Operating HTML 45K Lease Agreements (Detail) 69: R49 Summary of Option Activity (Detail) HTML 81K 25: R50 Options Outstanding and Exercisable (Detail) HTML 70K 66: R51 Cash Proceeds Along with Fair Value Disclosures HTML 41K Related to Grants Exercises and Vesting Options (Detail) 28: R52 Stockholders' Equity - Additional Information HTML 251K (Detail) 42: R53 Summary of Net Revenue by Geographic Location HTML 27K (Detail) 17: R54 Segment Information - Additional Information HTML 32K (Detail) 20: R55 Concentrations - Additional Information (Detail) HTML 36K 35: R56 Subsequent Events - Additional Information HTML 67K (Detail) 23: R57 Consolidated Valuation and Qualifying Accounts and HTML 36K Reserves (Detail) 74: XML IDEA XML File -- Filing Summary XML 111K 19: EXCEL IDEA Workbook of Financial Reports XLSX 190K 31: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.05M 10: EX-101.INS XBRL Instance -- biol-20131231 XML 2.69M 12: EX-101.CAL XBRL Calculations -- biol-20131231_cal XML 200K 13: EX-101.DEF XBRL Definitions -- biol-20131231_def XML 1.08M 14: EX-101.LAB XBRL Labels -- biol-20131231_lab XML 1.53M 15: EX-101.PRE XBRL Presentations -- biol-20131231_pre XML 1.21M 11: EX-101.SCH XBRL Schema -- biol-20131231 XSD 220K 59: ZIP XBRL Zipped Folder -- 0001564590-14-000856-xbrl Zip 215K
|
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/17/14 | 8-K/A, DEFA14A | ||
For Period end: | 12/31/13 | 10-K/A, SD | ||
12/31/12 | 10-K | |||
12/31/11 | 10-K, 10-K/A | |||
9/15/09 | ||||
List all Filings |